|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,1






* Department of Medicinal Chemistry and Natural Products, Medical Faculty, and
Department of Pharmacology, Pharmacy School, Hebrew University of Jerusalem, Jerusalem, Israel;
Gill Center for Biomolecular Science and Department of Psychological and Brain Sciences, Indiana University Bloomington, Bloomington, Indiana, USA;
Departments of Behavioral Sciences and of Molecular Biology, Ariel University Center of Samaria, Ariel, Israel;
|| Eli Lilly and Co., Neuroscience Division, Indianapolis, Indiana, USA;
¶ Research Department, Herzog Memorial Hospital, Jerusalem, Israel;
# School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel-Aviv University, Ramat Aviv, Israel; and
** Department of Biological Chemistry, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
1Correspondence: Department of Medicinal Chemistry and Natural Products, Medical Faculty, Hebrew University of Jerusalem, 91120, Jerusalem, Israel. E-mail: A.M., arieh{at}weizmann.ac.il; or R.M., mechou{at}cc.huji.ac.il
| ABSTRACT |
|---|
|
|
|---|
Key Words: Boswellia frankincense depression anxiety
| INTRODUCTION |
|---|
|
|
|---|
The resin of Boswellia species (Burseraceae; "frankincense" and "olibanum") is mentioned in numerous ancient texts as incense by itself or as a major component of incense (4)
. In the ancient Middle East, Boswellia resin was considered a highly precious commodity, carried in caravans from sub-Sahara regions, where it is still a major export product (5)
. In ancient Egypt, incense burning signified a manifestation of the presence of the gods and a gratification to them. In ancient Judea, it was a central ceremony in the temple. The ancient Greeks used incense burning as an oblation. In Christendom, its use in worship has continued since the fourth or fifth century C.E (6)
. The psychoactivity of Boswellia was already recognized in ancient times. Dioscorides (first century C.E.) writes that it causes madness (7)
. In the Jewish Talmud (300–600 C.E.), Boswellia resin is mentioned as a potion (in wine) given to prisoners condemned to death to "benumb the senses" (8)
. In Ethiopia, where Boswellia trees are indigenous, it is believed to have a tranquilizing effect (9)
. For additional data on the cultural and religious customs associated with Boswellia, see Supplemental Material.
In view of the prolonged use of Boswellia, its historical importance, and its significance in cultural and religious rituals along with its purported pharmacological effects, we investigated the biochemical profile and psychoactivity of purified components of Boswellia resin. We assumed that the spiritual exaltation caused by incense burning in religious ceremonies would be enhanced by putative pharmacological effects of its constituents, particularly on the conductors of the ceremonies, who presumably inhale large amounts of smoke. We are unaware of any attempt to identify constituents with an effect on sensation or emotion. Menon and Kar (10)
have reported that an ether extract of Boswellia serrata resin produces analgesic and sedative effects in rats, but the compounds causing these effects have not been isolated.
We examined Boswellia extract for the presence of novel bioactive components and isolated incensole acetate (IA) as a major active constituent of Boswellia resin. IA showed an antiinflammatory action, as recently reported by us (11
, 12)
, as well as several CNS-associated activities, described below. It is known as a macrocyclic diterpenoid (13)
, considered to be a biomarker of Boswellia species (14)
, but has not been previously evaluated for its psychoactivity.
To evaluate the activity profile of IA, we used behavioral, pharmacological, and physiological assays. They included standard behavioral mice models for the evaluation of anxiolytic and antidepressive drugs (elevated plus maze, Porsolts forced swimming test, open field behavior, and a test for catalepsy), c-Fos immunostaining, various receptor binding assays, and physiological measurements.
Transient receptor potential (TRP) channels are activated by multiple stimuli in expression systems and mediate transmembrane flux of cations (15)
. The TRP vanilloid (TRPV) channel subfamily consists of six members; TRPV1-TRPV4 comprise the so-called thermo-TRPVs and are activated by temperature and chemical stimuli. Although thermo-sensitive, TRPV channels are also expressed in tissues such as the brain, in which thermoregulatory homeostasis precludes dramatic temperature swings (15)
.
TRPV3 has a threshold for temperatures in the 31–39°C range, and it is highly expressed in epithelial cells of the skin and oropharynx (16
17
18)
, where its activation causes a feeling of warmth. mRNA encoding this channel has also been detected in the brain (17
, 18)
. Owing to the recent identification of TRPV3 ion channel, relatively few agonists are known for it. The first chemical agonist identified for TRPV3 was the synthetic broad spectrum TRP modulator 2-aminoethoxydiphenyl borate (2-APB; ref. 19
). Shortly afterward, the monoterpene camphor was found to be an agonist (20)
. In addition, carvacrol, thymol, and eugenol have recently been described to activate TRPV3 (21)
. The function of TRPV3 in the CNS remains to be elucidated.
| MATERIALS AND METHODS |
|---|
|
|
|---|
-Phorbol 12,13-didecanoate (4
PDD) was purchased from PKC Pharmaceuticals (Woburn, MA, USA). Pental was purchased from C.T.S. Chemical Industries (Tel Aviv, Israel). Rabbit anti c-Fos, horseradish peroxidase, and diaminobenzidine were purchased from Sigma. Secondary biotinylated donkey anti-rabbit antibody was purchased from Chemicon (Temecula, CA, USA).
IA and 4
PDD were dissolved in ethanol for in vitro assays; 2-APB, ionomycin, and capsaicin were dissolved in dimethyl sulfoxide (DMSO). All solvents were applied in a volume <1.1% of the total volume in the well, a concentration that did not induce effects on calcium mobilization or ion currents.
Cell culture
Human embryonic kidney (HEK) 293 cells stably expressing human TRPV1 were a kind gift from Merck Research Laboratories (Whitehouse Station, NJ, USA). Cells were cultured in minimal essential medium, Dulbecco modified Eagle medium (DMEM), modified with nonessential amino acids, 1 mM sodium pyruvate, 2 mM L-glutamine, and 1.5 g/l sodium bicarbonate (TACK, Manassas, VA, USA), containing 1% penicillin-streptomycin and 10% FBS. Cells were passaged 3 times a week using trypsin-EDTA 1x (Invitrogen, Carlsbad, CA, USA) and grown under 5% CO2 at 37°C.
HEK293 cells stably expressing mouse TRPV3-YFP, pcDNA3, and rat TRPV4 were acquired as described previously (20
, 22
, 23)
.
HEK293 cells were transiently transfected with a rat TRPV2 plasmid (24)
, using lipofectamine reagent (Invitrogen) according to manufacturers protocol. HEK293 cells expressing mouse TRPV3-YFP, pcDNA3, rat TRPV2, or rat TRPV4 were cultured in 1x DMEM (high glucose) with L-glutamine (Mediatech, Inc., Herndon, VA, USA), containing 1% penicillin-streptomycin (Invitrogen) and 10% FBS. Cells were passaged 3 times a week using 1x trypsin-EDTA (Invitrogen) and grown under 5% CO2 at 37°C.
Animals and procedures
Female Sabra mice (Harlan, Rehovot, Israel; 15–20 wk old) and wild-type (WT) C57BL/6 or TRPV3 knockout (KO) female mice (18–20 wk old; ref. 18
) were used for behavioral assessments. Ten mice were housed in each cage. The animal care and protocols met the guidelines of the U.S. National Institutes of Health, detailed in the Guide for the Care and Use of Laboratory Animals, and were applied in conformity with the Johns Hopkins University and Ariel University Center of Samaria Institutional Ethics Committees. Female Sabra mice were also used for the c-Fos immunostaining. Temperature in the animal room was maintained between 20–22°C; the light cycle was 12 h lights on (8 AM to 8 PM) and 12 h lights off (8 PM to 8 AM). Mice were injected intraperitoneally with IA in a mixture of isopropanol:cremophor:saline (1:1:18) at a volume of 10 µl/g body weight.
Behavioral assays
The different behavioral assays performed were all based on established assays. Preliminary observations indicated similar effects of IA when the time interval between injection and testing was between 15 and 45 min. Therefore, mice were assayed within these time limits.
Elevated plus maze
The elevated plus maze assay is based on the preference of mice for the closed arms of a maze, apparently due to fear of open spaces. The assay was performed as described by others (25
, 26)
. Briefly, mice were placed in the central platform (10x10 cm) between the open (10x45 cm) and closed (10x45x40 cm) arms of a plus maze. The time spent in each of the arms was recorded. An "antianxiety" effect was measured as the time spent on the aversive open arms of the maze (relative to the total time spent in both arms).
Porsolt forced swimming test
The Porsolt forced swimming test was based on previous designs (27
, 28)
: mice were placed in a 2 L glass beaker (11 cm diameter) filled with water (24±1°C) up to 30 cm from the bottom (so that the mouse could not touch the bottom) and 8 cm from the rim (so that the mouse could not escape). Immobility time was defined as the time the animal did not move (except for small movements required to float).
Open field behavior
Mice were placed in a transparent open field of 30 x 40 cm, divided into 20 squares of equal size, and their horizontal (ambulatory) and vertical activity was measured for 8 min by scoring the number of squares crossed (29
, 30)
and number of rears accordingly.
Cataleptic effect
The cataleptic effect of IA was measured as time of immobility on an elevated ring of 5.5 cm diameter (during 4 min; refs. 29
, 30
).
c-Fos immunostaining
Mice were deeply anesthetized by an intraperitoneal injection of 200 mg/kg sodium pentobarbital (Pental). Brains were fixed by transcardial perfusion with ice-cold 4% paraformaldehyde containing 4% sucrose (pH 7.4) and by overnight immersion in the same, refrigerated fixative. Brains were then immersed in 12% sucrose in PBS (0.02 M, pH 7.4) and kept refrigerated until sectioning. Brains were cut on a cryostat as coronal sections, 30 µm thick, and were collected floating and kept in a cryopreservation buffer at –18°C until immunohistochemical staining of c-Fos. For each brain region, two fields were sampled containing this region from the right and left hemisphere. After the sections were rinsed in PBS (0.02 M, pH 7.4) and quenched of endogenous peroxidase by incubation in 0.15% hydrogen peroxide for 30 min, they were incubated with rabbit anti c-Fos diluted 1:5000. The secondary antibody was diluted 1:400, and sections were incubated with extravidin conjugated with horseradish peroxidase diluted 1:200. The final color reaction was performed with diaminobenzidine.
Binding assays
All binding assays were performed under license agreement at Cerep (Paris, France; refs. 31
, 32
).
Calcium imaging of HEK293 cells
Human TRPV1-, mouse TRPV3-YFP-, rat TRPV4-, and pcDNA3-expressing HEK293 cells were plated 24–48 h before imaging in 96-well black walled, clear bottom CellBind plates (Corning, Corning, NY, USA), loaded with 3 µM Fura-2 AM, and imaged as described previously (33)
. For single-cell calcium imaging, HEK293-rat TRPV2- and -mouse TRPV3-YFP-expressing cells were plated on collagen-coated glass cover slips. Cells were loaded for 60 min with 3 µM Fura-2 AM in 0.05% w/v pluronic 127 in HEPES-Tyrode buffer (pH 7.4) containing the following (in mM): 25 HEPES, 140 NaCl, 2.7 KCl, 1.8 CaCl2, 0.5 MgCl2, 0.4 NaH2PO4, and 5 glucose. All experiments were performed at room temperature (
24°C). A Flexstation II plate reader (Molecular Devices) was programmed with the following settings: excitation wavelength, 340 and 380 nm; emission wavelength, 510 nm. The initial volume per well was 175 µl. After 30 s of baseline recording, 75 µl buffer containing drug or vehicle was added at a rate of up to
52 µl/s per well. The total run time was 200 s. For single-cell calcium imaging experiments, coverslips were mounted on an inverted microscope (Nikon TS-100, Tokyo, Japan). Cells were alternately excited at 340 and 380 nm. Emitted light (510 nm) was captured using a Cohu 4920 cooled charge-coupled device (CCD) camera (Cohu, San Diego, CA, USA) and analyzed with the InCyt Im2 image acquisition and analysis software (Intracellular Imaging Inc., Cincinnati, OH, USA).
Calcium imaging of TRPV3+/+ and TRPV3–/– keratinocytes
Primary keratinocytes from TRPV3-deficient and TRPV3+/+ mouse pups (days 1–4) were harvested and cultured as described previously (34)
. Cells were plated on glass coverslips (105/cm2) and incubated for 48–60 h and then loaded with Fura-2 AM (20 µM, 0.04% pleuronic acid, 32°C for 1 h) in imaging buffer containing the following (in mM): 130 NaCl, 2.5 CaCl2, 0.6 MgCl2, 10 HEPES, 1.2 NaHCO3, and 10 glucose, pH 7.45. Ratiometric Ca2+ imaging was performed as described previously (22)
. Drug was added to the bath after a period of baseline recording. Calcium measurements were made from 30 randomly selected cells per coverslip (the cells were not chosen based on criteria such as morphology or labeling).
Electrophysiological recording
Currents were recorded using whole-cell voltage clamp. Pipettes were pulled from microcapillary glass (A-M Systems, Sequim, WA, USA). A coverslip containing cells was transferred to a 300 µl chamber that was constantly perfused (1–2 ml/min) with external solution. Voltage protocols were generated and data were digitized and recorded using Pulse (HEKA Elektronik, Lambrecht, Germany) software in conjunction with an Axopatch 200A amplifier (Axon Instruments, Foster City, CA, USA). The data were analyzed using an in-house Visual Basic (Microsoft, Redmond, WA, USA) analysis program.
The pipette solution contained the following (in mM): 121.5 K gluconate, 10 HEPES, 17 KCl, 9 NaCl, 1 MgCl2, 0.2 EGTA, 2 MgATP, and 0.5 NaATP, pH 7.2. The external solution contained the following (in mM): 120 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 glucose, and 20 HEPES, pH 7.4, with NaOH. The measured charge (pC) was defined as the charge elicited between –85 and –45 mV by a ramping voltage stimulus (–85 mV to +35 mV, 0.54 mV/ms; holding potential –55 mV). Currents were sampled at 5 kHz. Experimental and control cells were alternated whenever possible. Control values were obtained from WT HEK293 cells.
Data analysis
In general, for comparisons between two data sets we used an unpaired 2-tailed Students t test. For tests of statistical significance involving more than two data sets, we used a 1-way ANOVA with a post hoc test, because this test is appropriate for comparing three groups on one factor. Data obtained from the KO vs. WT mice in
Fig. 7
were analyzed by 2-way ANOVA because in this case two factors were investigated (strain: WT vs. KO; and drug: vehicle vs. IA). Behavioral responses in Sabra mice to IA vs. diazepam or desipramine were analyzed by 1-way ANOVA with Newman-Keuls post hoc comparisons. Motor behavior and catalepsy data were analyzed by t tests (comparing vehicle- and IA-injected mice), and behaviors in C57BL/6 (WT) vs. TRPV3–/– mice were analyzed using 2-way ANOVA with Bonferroni post hoc comparisons (GraphPad 4 Prism; GraphPad, San Diego, CA, USA). Analysis of calcium imaging data was performed using a nonlinear regression curve fit (GraphPad 4 Prism). In the keratinocyte experiments, drug-induced response for each cell was taken as the maximal postdrug measurements over time minus the average of the last 5 predrug measurements. Averaged drug responses over 30 randomly selected cells per coverslip were analyzed with 2-tailed unpaired t tests.
|
|
|
|
|
|
|
For analysis of c-Fos immunoreactivity, positive nuclei were identified based on their round form and optical density at least twice that of background. The numbers of c-Fos immunoreactive nuclei from the right and left hemispheres were averaged to obtain a representative number for the given region from each mouse. Student t tests were performed comparing the control (vehicle) with the IA group.
| RESULTS |
|---|
|
|
|---|
The experiments described in Figs. 2
and 3
are representative of 4 to 7 independent experiments, and all gave comparable results. It should be noted that while the experiments presented in Fig. 2
are designed to reflect the emotional state of the examined animal, the open field locomotion and the ring catalepsy tests, presented in Fig. 3
, reflect the motor effects of IA.
IA modulates the expression of c-Fos in mice brains in several areas, including areas involved in anxiety and depression
To investigate the activity of IA on different brain regions, we studied its effect on c-Fos immunoreactivity in mouse brains 60 min after administration (50 mg/kg ip). IA significantly increased c-Fos in the lateral septum, central nucleus of the amygdala, and solitary nucleus, while significantly reducing c-Fos in the motor cortex, medial striatum, and hippocampal CA3 region (Fig. 4
; Table 1
; Supplemental Fig. 1).
|
Binding assays
IA was assayed for its ability to displace radioligands bound to an array of 24 receptors, ion channels, and transport proteins potentially relevant to its putative emotional and behavioral effects (Supplemental Table 1). No significant displacement of radioligand was observed for any of these targets using up to 10 µM of IA (data not shown).
IA activates TRPV3 channels, but not several other TRPV channels, as determined by calcium imaging
Our attention then turned to the TRPV family of channels, especially as TRPV1 is assumed to mediate behavioral effects that resemble those exhibited by IA (35)
. We hence proceeded to examine the effect of IA on TRPV1–4. IA significantly increased calcium influx (EC50=16 µM; Hill slope=2.2; Fig. 5
A, B, D) in HEK293 cells stably expressing mouse TRPV3-YFP. When calcium was removed from the extracellular medium, the calcium increase in response to IA was significantly reduced (Fig. 5B
), providing further evidence for the influx of calcium through TRPV3 channels. The effect of IA on TRPV3-induced calcium influx resembles the effect of the broad-spectrum TRP agonist 2-APB, which served as a positive control (Fig. 5A, D
). IA (500 µM) also induced a calcium influx in primary keratinocytes from WT mice but not from TRPV3–/– mice (Fig. 5C
). The effect of IA (500 µM) on TRPV-induced calcium influx in primary keratinocytes resembles the one of camphor (10 mM), a known agonist of TRPV3. Interestingly, at a concentration (100 µM) that was maximally effective in TRPV3 expressing cells, IA did not induce calcium influx in HEK293 cells transiently transfected with rat-TRPV2 (Fig. 5F
) and caused only minimal calcium influx in HEK293 cells expressing human TRPV1 and rat TRPV4 (Fig. 5E, G
).
IA activates a TRPV3 current in HEK293 cells
IA also activated a cation current in mouse-TRPV3-YFP-expressing HEK293 cells (Fig. 6
A–C) with properties consistent with TRPV3 activation (36)
. This current was lower than the current activated by 2-APB, which served as a positive control (Fig. 6D
). IA-induced current was not activated in HEK293 cells not expressing TRPV3 nor in TRPV1 or TRPV4 expressing cells (Fig. 6C, E
).
IA exerts anxiolytic-like and antidepressive-like effects in WT but not in TRPV3 KO mice
Given the effect of IA on TRPV3 channels and the observation that IA does not interact with a long list of receptors known to be involved in psychoactivity, we investigated the possibility that its behavioral effects are mediated through CNS TRPV3 channels. We repeated the panel of behavioral assays with WT and TRPV3–/– mice, which were administered either IA or vehicle. IA (75 mg/kg) exerted a significant anxiolytic-like effect in WT mice, while TRPV3–/– mice spent identical time on the open arms, regardless of whether they were injected with IA or only vehicle (Fig. 7
A; Fstrain=6.3, df=1,14, P<0.05; Finteraction=5.0, df=1,14, P<0.05). In the Porsolt forced swimming test, IA significantly reduced the immobility time in WT but not in TRPV3–/– mice (FIA=5.5, df=1,16, P<0.04; Finteraction=5.9, df=1,16, P<0.03; Fig. 7B
). No significant differences were recorded between vehicle-treated WT mice and vehicle-treated TRPV3–/– mice in the Porsolt forced swimming and elevated plus maze assays. The decreased locomotion and cataleptic effects of IA were maintained in TRPV3–/– mice (Fig. 8
).
|
| DISCUSSION |
|---|
|
|
|---|
IA as a novel anxiolytic and antidepressive agent
Anxiety and depression are the most common forms of psychiatric disorders in the United States (37
, 38)
and pose risk factors for numerous additional diseases (39)
. The clinical treatment of these high-prevalence disorders often relies on pharmacologic interventions. However, although antianxiety and antidepressive drugs have been developed, new types of such medicaments are needed, as the presently available treatments are not satisfactory in many cases, due to treatment-limiting adverse effects (40
, 41)
. Finding new drugs for the amelioration of anxiety and depression is thus of considerable significance and even more so is the search for new pharmacological targets that can be addressed in this quest.
c-Fos transcription factor is a product of an immediate early gene, and changes in its expression serve as markers of changes in neuronal activity. It is used in histological sections to map out brain regions that are activated or attenuated after treatment with psychoactive drugs, such as anxiolytics and antidepressants (42
, 43)
. The central nucleus of the amygdala and the lateral septum play major roles in the expression of emotions (44
, 45)
, and it is assumed that c-Fos expression in the central nucleus of the amygdala is due to circuits that are engaged by both anxiolytic and anxiogenic drugs (44)
.
We found that IA shows significant TRPV3-dependent activity in both the elevated plus maze and the Porsolt forced swimming test. Despite minor differences, which are expected in different strains, IA maintains significant behavioral effects on both Sabra mice and WT C57BL/6 mice, generalizing and corroborating its putative psychoactive effect. It should be noted that these behavioral assays are independent from the locomotion open field test. Hence, despite the significant attenuation of locomotion, IA significantly decreased the time mice spend immobile in water. IA also modulates the expression of c-Fos in mice brains in several areas, including areas involved in anxiety and depression (Fig. 4)
. Thus, the data from the behavioral assays together with the c-Fos immunostaining suggest that IA may represent a novel anxiolytic and antidepressive agent. Our next step was to look for a possible mechanism for these behavioral effects. Considering its effects on animal models, we were surprised to note that IA does not bind to any of 24 related receptors, ion channels, and transport proteins. However, we found that it is a potent TRPV3 channel activator.
IA is a potent TRPV3 activator
In view of the critical role played by natural products in the discovery of the TRP channels and their functions (46)
, several groups have recently attempted to identify natural products that activate TRPV3 channel. Smith et al. (47)
have screened extracts from 50 Chinese herbal plants; no TRPV3 active compounds were identified. Vogt-Eisele et al. (48)
examined a library of monoterpenoids for their action on TRPV3 and found some of them to be active, the lowest EC50 reported as 370 µM.
As described above (Fig. 5A, B, D
), we found that IA induces calcium influx in HEK293 cells expressing TRPV3 channel. This observation was confirmed by the activation of TRPV3 in primary mouse keratinocytes (Fig. 5C
) and by the activation of a TRPV3 current in HEK293 cells stably expressing TRPV3 (Fig. 6A-D
). The effect of IA on TRPV3-induced calcium influx resembles the effect of 2-APB, the most potent known TRPV3 activator (Fig. 5D
). However, its effect on cell current is lower (Fig. 6)
. The effect elicited by IA on TRPV3 channels seems to be more specific than that by 2-APB, as it showed no or very modest activity on cells expressing TRPV2, TRPV1, or TRPV4 (Figs. 5E-G
and 6E
). Because the charge response to IA lags the calcium response, it is possible that a calcium-activated current is evoked in the cells. However, this difference can be attributed to the inherent differences between the calcium imaging system and an electrophysiology apparatus, e.g., differences in the ions measured or in drug application (manual application vs. perfusion system).
Terpenoids have been used for centuries as medicinally useful compounds, but still little is known about the mechanism of action of many of them (48)
. TRP channels as targets for terpenoids can potentially explain several of their described effects. Investigations of novel ligands for members of the TRP channel family are not only relevant for the understanding of this protein family but may also have implications for target-directed drug design (48)
.
TRPV3 channel may pose a possible novel therapeutic target in the CNS
Our data, in particular the observations that IA has no effect in the elevated plus maze and the Porsolt forced swimming test in TRPV3–/– mice, indicate that the TRPV3 channels are involved in the effects of IA in animal models for antidepressant and anxiolytic effects. This implies that TRPV3 channels in the brain may play a role in emotional regulation, thus attributing, for the first time, a function for this channel in the CNS. These data also raise hopes that TRPV3 channels in the brain may be targeted in the efforts of ameliorating depressive and anxiety disorders. Our observation that IA reduces activity in the open field and the ring tests to the same extent in both TRPV3–/– and WT mice implies that the sedation produced by IA is not mediated via TRPV3 channels.
IA is chemically unrelated to compounds that are currently in use as anxiolytic and antidepressive drugs. It belongs to an important group of common natural products, cembranoid diterpenes. Many of these compounds exhibit biological activities; however, to the best of our knowledge, no work has been done on the CNS activities of these compounds to date. The identification of CNS effects by a cembranoid diterpene may lead to a novel group of antidepressive and anxiolytic agents, originating from an ancient drug.
Taken together, our data support our original contention, namely that Boswellia resin may affect sensation and emotional states. These observations also indicate that the TRPV3 channel is involved in emotional and behavioral processes in the CNS in addition to its known effects on the perception of warmth (thermosensation). It is possible that IA augments the euphoric feeling produced during religious functions, due to both positive, presumably mild, emotional effects and the sensation of warmth. Thus the neurobehavioral effect of IA may provide a biochemical basis for the millennial and widespread use of Boswellia-containing incense. However, only direct human trials including the investigation of human dosage and dosage forms may give final, concrete proof.
Thus, IA joins the notable group of plant-derived compounds that are active in the mammalian CNS. It is therefore possible that IA would provide us with novel therapeutic agents and neurochemical insights.
| ACKNOWLEDGMENTS |
|---|
Received for publication December 17, 2007. Accepted for publication April 10, 2008.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Vriens, G. Appendino, and B. Nilius Pharmacology of Vanilloid Transient Receptor Potential Cation Channels Mol. Pharmacol., June 1, 2009; 75(6): 1262 - 1279. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |